RxDoctor Payments Data

Dustin Gardner

Optometrist · Marysville, OHNPI 1366720922

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (30.7%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Johnson & Johnson Vision Care, Inc. at 55.9% of the total. Reporting peaked in 2019 at $3,650 and has fallen 98.4% since, to $59 in 2025. Among optometrist clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,457in general payments, 2019–2025

Across 63 payments — averaging $118.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson Vision Care, Inc.$4K
  • Alcon$2K
  • Coopervision Inc.$1K
  • Biotissue Holdings Inc.$19
  • Sun Pharmaceutical Industries Inc.$12
$306,237in research payments, 2019–2025

Across 193 payments — averaging $1586.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Johnson & Johnson Vision Care, Inc.$161K
  • Alcon Research LLC$115K
  • Coopervision Inc.$30K

What the payments were for

  • Consulting fees$2,25030%
  • Speaking & faculty fees$1,50020%
  • Travel & lodging$2,28931%
  • Food & beverage$1,41919%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,457 in reported general payments places this provider in the 95th percentile of 1,995 optometrist providers in Ohio.

See all optometrist providers in Ohio

Medicare billing

Part B allowed, 2024
$27,469
Medicare patients
184
Services billed
314

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost53$268

Paid to pharmacies, not to this prescriber.

Other optometrist in Marysville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →